XBiotech: Rises on accelerating antibody therapy for COVID-19
Brief: XBiotech Developing Novel True Human Antibody Targeting Interleukin-1Alpha
U.S. STOCKS ON THE MOVE-Gilead Sciences, Wayfair, Immunomedics, Akers Bioscience
U.S. STOCKS ON THE MOVE-Carnival Corp, Capri Holdings, Kohl's, Immunomedics
U.S. STOCKS ON THE MOVE-Kohl's, Carnival Corp, Akers Bioscience, Immunomedics
U.S. STOCKS ON THE MOVE-Borr Drillng, Millendo Therapeutics, Menlo Therapeutics, Immunomedics Inc
U.S. STOCKS ON THE MOVE-Crescent Point Energy, Millendo Therapeutics, Menlo Therapeutics
XBiotech: Jumps on collaboration to develop COVID-19 treatment
Brief: Xbiotech And Biobridge Global Collaborate On FDA Program To Develop Potential COVID-19 Treatment Based On Natural Antibodies From Recovered Patients
XBioTech Inc: Surges to near 5-yr high on $420 mln share repurchase
Brief: Xbiotech Commences Tender Offer To Purchase Up To $420,000,000 Of Its Shares
Brief: XBiotech Added To Nasdaq Biotechnology Index
XBiotech surges on sale of anti-inflammatory drug to Janssen
XBiotech soars on $750 mln deal to sell anti-inflammatory drug to Janssen
U.S. STOCKS ON THE MOVE-PG&E, Canopy Growth, 3M, Synthorx, Macy's, Qorvo
Brief: XBiotech Announces Agreement To Sell True Human Antibody Bermekimab Targeting Il-1A To Janssen
Brief: Janssen To Acquire Investigational Bermekimab From Xbiotech
Brief: XBiotech Announces First Patient Enrolled In Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy In Patients With Hidradenitis Suppurativa
Brief: Xbiotech Announces First Patient In Clinical Study To Evaluate Bermekimab